← Back to Analyst Consensus 
GMAB Buy
GENMAB A/S
Current Price —
Implied Upside —
Analysts 26
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 4 reiterations from 3 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Oct 7, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Oct 7, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Oct 5, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Sep 14, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 7, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jul 22, 2026 | TD Cowen | upgrade | Hold → Buy | — | 54% |
| Jul 2, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jun 23, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 30, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 27, 2026 | Wolfe Research | initiate | — → Outperform | — | 54% |
| Mar 2, 2026 | Wells Fargo | initiate | — → Overweight | — | 54% |
| Feb 23, 2026 | Guggenheim | maintain | Buy → Buy | $40 | 52% |
| Feb 18, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $40 | 44% |
| Jan 28, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $39 | 44% |
| Jan 20, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $39 | 44% |
| Nov 10, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $41 | 44% |
| Nov 7, 2025 | Truist Securities | reiterate | Buy → Buy | $48 | 54% |
| Oct 15, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Oct 2, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $40 | 44% |
| Sep 24, 2025 | Guggenheim | upgrade | Neutral → Buy | $43 | 52% |
| Sep 23, 2025 | Guggenheim | upgrade | Neutral → Buy | $43 | 52% |
| Aug 15, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $36 | 44% |
| Jul 8, 2025 | Truist Securities | maintain | Buy → Buy | $46 | 54% |
| May 13, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $35 | 44% |
| Apr 9, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $37 | 44% |
| Mar 11, 2025 | Truist Securities | maintain | Buy → Buy | $45 | 54% |
| Mar 11, 2025 | William Blair | upgrade | Market Perform → Outperform | $0 | 48% |
| Feb 13, 2025 | Leerink Partners | upgrade | Market Perform → Outperform | $27 | 50% |
| Jan 23, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Jan 22, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Jan 8, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $50 | 44% |
| Nov 8, 2024 | BMO Capital | reiterate | Outperform → Outperform | $48 | 53% |
| Oct 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Sep 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Sep 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Sep 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Sep 11, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $31 | 54% |
| Sep 9, 2024 | Truist Securities | maintain | Buy → Buy | $50 | 54% |
| Aug 27, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Aug 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Aug 20, 2024 | JP Morgan | downgrade | Overweight → Neutral | $0 | 55% |
| Aug 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Aug 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Aug 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Jul 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Jul 15, 2024 | RBC Capital | upgrade | Sector Perform → Outperform | $0 | 55% |
| Jun 27, 2024 | BTIG | maintain | Buy → Buy | $47 | 52% |
| Jun 27, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Jun 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
Price Target Trend
Jun 7, 2026 Oct 26, 2026
EPS Estimates
0q —
+1y —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days